Drug Therapy
News
Prices, out-of-pocket costs for MS drugs rose despite competition
Rather than decreasing prices, the introduction of new self-administered therapies after 2009 may have contributed to increased prices.
FDA/CDC
Calquence earns breakthrough designation for CLL monotherapy
The Bruton tyrosine kinase inhibitor is already approved for the treatment of adults with mantle cell lymphoma who have received at least one...
News
High-dose vitamin D for bone health may do more harm than good
A randomized trial showed an inverse dose-response relationship between high-dose vitamin D supplementation and bone quality in healthy adults.
News
FDA approves Taltz for treatment of ankylosing spondylitis
The approval is based on results from a pair of randomized, double-blind, placebo-controlled, phase 3 studies involving 657 adult patients with...
Conference Coverage
Intranasal midazolam as first line for status epilepticus
BANGKOK – “Time is brain,” said Dr. Lara Kay.
Conference Coverage
‘Pot’ is still hot for Dravet, Lennox-Gastaut
BANGKOK – Long-term extension studies show sustained, consistent seizure reductions.
News
ASCO VTE guideline update: DOACs now an option for prevention, treatment
Updates to the ASCO guideline for VTE prophylaxis and treatment in cancer patients center largely on recent findings regarding direct...
News
Pediatric, adolescent migraine treatment and prevention guidelines are updated
The guidelines review both pharmacologic and nonpharmacologic options, which have multiplied since the previous guidelines were released in 2004...
News
FDA approves drug combo to treat highly resistant TB
Conference Coverage
Treatment of episodic cluster headache deviates from recommendations
PHILADELPHIA – Among patients with episodic cluster headache, use of acute medications is high, but use of...